Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis

Global tuberculosis report (2014)

Gabbasova, L. A., & Who, E. R. E. (2014) · Cited by 12,702

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

Gandhi, N. R., Moll, A. P., Sturm, A. W., Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J. R., & Friedland, G. H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69573-1 · Cited by 1,732

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

Falzon, D., Jaramillo, E., Schünemann, H. J., Arentz, M., Bauer, M., Bayona, J. N., Blanc, L., Caminero, J. A., Daley, C. L., Duncombe, C. J., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00073611 · Cited by 1,098

The Emergence of Drug-Resistant Tuberculosis in New York City

Frieden, T. R., Sterling, T. R., Pablos-Méndez, A., Kilburn, J. O., Cauthen, G. M., & Dooley, S. W. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302253280801 · Cited by 937

Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis

Deun, A. V., Maug, A. K. J., Salim, M. A. H., Das, P. K., Sarker, M. R., Daru, P., & Rieder, H. L. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0077oc · Cited by 646

Tuberculosis in New York City — Turning the Tide

Frieden, T. R., Fujiwara, P. I., Washko, R. M., & Hamburg, M. A. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330406 · Cited by 644

National survey of drug-resistant tuberculosis in China.

Zhao, Y.-L., Xu, S., Wang, L.-X., Chin, D., Wang, S.-F., Jiang, G., Xia, H., Zhou, Y., Li, Q., Ou, X.-C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108789 · Cited by 637

Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients

Ahuja, S. D., Ashkin, D., Avendano, M., Banerjee, R., Bauer, M., Bayona, J. N., Becerra, M. C., Benedetti, A., Burgos, M. V., Centis, R., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001300 · Cited by 532

Community-Based Therapy for Multidrug-Resistant Tuberculosis in Lima, Peru

Mitnick, C., Bayona, J., Palacios, E., Shin, S., Furin, J., Alcántara, F., Sánchez, E., Sarria, M., Becerra, M., Fawzi, M. C. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022928 · Cited by 489

HIV Infection and Multidrug‐Resistant Tuberculosis—The Perfect Storm

Wells, C. D., Cegielski, J. P., Nelson, L. J., Laserson, K. F., Holtz, T. H., Finlay, A. M., Castro, K. G., & Weyer, K. (2007) · The Journal of Infectious Diseases · doi:10.1086/518665 · Cited by 483

Chondroitin sulfate anchored biodegradable nanoparticles: Design, synthesis, and In-vitro anti-tubercular efficacy

Mazahir, F., Sahoo, R. K., Gupta, U., & Yadav, A. K. (2023) · Materials Today Communications · doi:10.1016/j.mtcomm.2023.105364 · Cited by 2

Identification of potential compounds for the management of multidrug-resistant tuberculosis using computational methods

Gatwiri, W., & Kagia, R. (2023) · F1000Research · doi:10.12688/f1000research.130024.1 · Cited by 2

Influential Factors in TB/HIV Co-Infection Among HIV-Positive Patients at Jinja Regional Referral Hospital, Uganda

Benjamin, M. (2023) · IDOSR JOURNAL OF BIOLOGY CHEMISTRY AND PHARMACY · doi:10.59298/idosr/jbcp/23/11.1118 · Cited by 2

Association of Multidrug-Resistant Tuberculosis (MDR-TB) Patients on Profile of Liver and Kidney Function

Muda, I., Adam, M. F., Saputra, R., Muhyi, A., Noprianto, D., & Aminuddin, M. (2023) · Jurnal Kesehatan Pasak Bumi Kalimantan · doi:10.30872/j.kes.pasmi.kal.v5i2.9640 · Cited by 2

Towards the Design of a Gamified Application to Increase Tuberculosis Treatment Adherence in Vietnam

Wortberg, A., Perscheid, G., Moormann, J., & Vo, L. N. (2023) · Hawaii International Conference on System Sciences (HICSS) · doi:10.24251/hicss.2023.387 · Cited by 2

A Clinical TB Detection Method Based on Molecular Typing Technique with Quality Control

Feng, T., Yan, C., Yu, S.-W., Jiang, F., Su, M., & Chen, J. (2019) · Computational and Mathematical Methods in Medicine · doi:10.1155/2019/9872425 · Cited by 2

Low Detection Rate of Multidrug-Resistant and Rifampicin-Resistant Tuberculosis in the Democratic Republic of Congo: Trend Analysis 2013-2017

Kashongwe, I. M., Mawete, F., Ofali, L., Kaswa, M. K., Bompeka, F. L., Ntumba, J. M. K., & Kashongwe, Z. M. (2019) · Journal of Tuberculosis Research · doi:10.4236/jtr.2019.74020 · Cited by 2

Nanomedicine and Its Applications in Combating Resistance Relating to Opportunistic Pathogens With Special Reference to Tuberculosis

Shrivastava, P., Gautam, L., Jain, A., Vishwakarma, N., Vyas, S., & Vyas, S. P. (2021) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-7998-5049-6.ch004 · Cited by 2

Impact of multidisciplinary approach in managing pott spine - A case report

Lakhwani, M. G., Raipure, A., Seth, N. H., & Phansopkar, P. A. (2022) · Medical Science · doi:10.54905/disssi/v26i123/ms180e2192 · Cited by 2

Early pregnancy combined with acute hematogenous disseminated pulmonary tuberculosis leading to stillbirth: a case report

Liu, Y., Jing, A., & Hong, Y. (2022) · Annals of Palliative Medicine · doi:10.21037/apm-22-798 · Cited by 2

Nanotherapeutics of Phytoantioxidants for Microbial Infections

Bhushan, R., Upadhyay, S., & Rudrapal, M. (2022) · Wiley eBooks · doi:10.1002/9781119811794.ch14 · Cited by 2

Boronic acid derivative inhibits LexA mediated SOS response in MycobacteriaPreprint

Chatterjee, C., Mohan, G. R., Chinnasamy, H. V., Biswas, B., Sundaram, V., Srivastava, A., & Matheshwaran, S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.15.567215 · Cited by 2

Mycobacterium tuberculosis exploits SIRT2 for iron acquisition to facilitate its intracellular survivalPreprint

Talukdar, S., Modanwal, R., Chaubey, G. K., Dhiman, A., Dilawari, R., Raje, C. I., & Raje, M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.05.574348 · Cited by 2

PPARγ mediated enhanced lipid biogenesis fuels Mycobacterium tuberculosis growth in a drug-tolerant hepatocyte environmentPreprint

Sarkar, B., Singh, J., Yadav, M., Sharma, P., Sharma, R., Singh, S., Chandramouli, A., Mehdiratta, K., Kumar, A., Kamat, S. S., et al. (2025) · bioRxiv · doi:10.7554/elife.103817 · Cited by 6

Pattern of drug resistant Mycobacterium tuberculosis in the west and northwest of Iran, a meta-analysis

Ansarin, K., & Sahebi, L. (2022) · Iranian Journal of Microbiology · doi:10.18502/ijm.v14i3.9754 · Cited by 1

CBNAAT: Advantage and Efficacy in Pulmonary Tuberculosis (PTB) atop on Traditional Methods for Diagnosis in a Tertiary Care Hospital in India

Bisht, H. S., Rajput, M. S., Tiwari, S., Kaur, S., & Gaur, V. (2022) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2022/v34i52a7212 · Cited by 1

Deciphering the mechanism of resistance by novel double mutations in pncA in Mycobacterium tuberculosis using protein structural graphs (PSG) and structural bioinformatic approaches

Alshabrmi, F. M., & Alatawi, E. A. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.106599 · Cited by 1

Carvacrol and its Semi-synthetic Derivatives as Potential Antibacterial Agents

Castro, I. H., Oliveira, F. A. A., Perez, C. C., & Bispo, M. D. L. F. (2023) · Revista Virtual de Química · doi:10.21577/1984-6835.20230020 · Cited by 1

Prevalence, Profile and Treatment Outcome of Tuberculosis-Human Immunodeficiency Virus Co-Infection in South Eastern Nigeria: A 3-Year Retrospective Study

Chukwuocha, I., Johnson, S. M., & Aguoru, E. P. (2024) · PubMed Central · doi:10.60787/nmj-64-6-372 · Cited by 1

Multi-drug resistant gene mutation analysis in Mycobacterium tuberculosis by molecular techniques

Sultana, M., Alam, M. M., Mistri, S. K., Kamal, S. M. M., Ahsan, C. R., & Yasmin, M. (2024) · Iranian Journal of Microbiology · doi:10.18502/ijm.v16i4.16304 · Cited by 1

Integrating structure-guided and fragment-based inhibitor design to combat bedaquiline resistant Mycobacterium tuberculosis : a molecular dynamics study

Roy, A., Banerjee, P., Paul, I., Ghosh, R., & Ray, S. (2024) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2024.2441426 · Cited by 1

Glutathione Depletion Exacerbates Hepatic Mycobacterium tuberculosis Infection

Sasaninia, K., Mohan, A. S., Badaoui, A., Glassman, I., Yoon, S., Karapetyan, A., Kolloli, A., Kumar, R., Ramasamy, S., Subbian, S., et al. (2025) · Biology · doi:10.3390/biology14020131 · Cited by 1

Microbicidal mechanisms for light-activated molecular nanomachines in Mycobacterium smegmatis: A model for pathogenic bacteria

Galbadage, T., Liu, D., Tour, J. M., Cirillo, J. D., & Gunasekera, R. S. (2025) · OpenNano · doi:10.1016/j.onano.2025.100240 · Cited by 1

Molecular Diagnosis of Drug-Resistant Mycobacterium tuberculosis Isolates Using IS6110 Gene in Tuberculosis Patients

Sheybani, A. Z., Hoseinzadeh, S., & Habibnia, S. (2024) · Iranian Journal of Medical Microbiology · doi:10.30699/ijmm.18.4.265 · Cited by 1

Combating TB Pathology: Advanced Diagnostics, Innovative Therapies, and Public Health Strategies: A Review

Mohanty, S., Khanna, M., Adhikary, K., Mukherjee, T., Sahu, A., Kahwa, I., Prabhakar, P. K., Swain, M. P., Sahoo, A., & Parida, M. K. (2025) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010355430250330074301 · Cited by 1

Targeted drug delivery to the macrophagic cellular tropics in tuberculosis

Rout, B., Peddinti, V., Agnihotri, T. G., Devaraj, & Jain, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24035-5.00014-1 · Cited by 1

Exploring natural inhibitors of Mycobacterium tuberculosis glutamine synthetase using molecular modeling, scaffold hopping, and machine learning-based bioactivity prediction

Ali, A., Ali, A., Khan, A., & Imran, M. (2025) · Journal of the Indian Chemical Society · doi:10.1016/j.jics.2025.101860 · Cited by 1

An update on Linezolid resistance in Mycobacterium tuberculosis and the challenges ahead

Singh, A., Chauhan, V., Kumar, C., Basil, M. V., & Prakash, A. (2025) · Egyptian Journal of Chest Diseases and Tuberculosis · doi:10.4103/ecdt.ecdt_81_24 · Cited by 1

Comparing the longer regimen and the shorter regimen for multidrug-resistant pulmonary tuberculosis patients treated under the programmatic management of drug-resistant tuberculosis

Karnan, A., Jadhav, U. S., Ghewade, B., & Alone, V. D. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1645820 · Cited by 1

Impaired Lung Function and Quality of Life Outcomes in Patients with Tuberculosis: A Cross-Sectional Study

Jagadeesh, V., Chikkahonnaiah, P., Dubey, M., Byrappa, S. H., Sridhar, H. B., Amachawadi, R. G. G., & Veeranna, R. P. (2025) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed10090247 · Cited by 1

Targeting Mycobacterium tuberculosis InhA with Phytochemicals: Insights from Molecular Docking and Dynamics Simulations

Singh, J., Virdi, V., Singh, K., Sharma, R., & Verma, D. K. (2025) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.19.3.56 · Cited by 1

Applying prior knowledge of regulatory signaling to investigate macrophage cAMP dynamics during Mycobacterium tuberculosis infection

Chen, C., Saha, P., Reimer, J., Wachter, S., Chen, J., Dhar, N., & Broderick, G. (2026) · Scientific Reports · doi:10.1038/s41598-026-62042-z · Cited by 1

Synthetic and In Silico strategies toward DprE1 inhibitors: Advancing antitubercular therapies

Gawad, J., Bonde, C. G., Palkar, M. B., Dhokchawle, B. V., Sharma, M., Gajbhiye, S. S., & Mhatre, V. (2025) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2025.100087 · Cited by 1

Key Proteins and Enzymatic Mechanisms Underlying Drug Resistance in Mycobacterium tuberculosis

Farnia, P., Velayati, A. A., Ghanavi, J., & Farnia, P. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-96883-9_9 · Cited by 1

The quantity and severity of adverse drug reactions experienced by patients with multi-drug resistant tuberculosis in the Ugu District

Ramasir, S., Oosthuizen, F., & Bangalee, V. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11901-7 · Cited by 1

Press-Through Packaging versus Bold and Slim Bottle-Type Containers: A Comparative Evaluation of Drug Packaging Usability in Patients with Rheumatic Diseases

Sadamoto, K., Morio, Y., Ura, H., & Kubota, K. (2025) · Patient Preference and Adherence · doi:10.2147/ppa.s561772 · Cited by 1

Drug resistance patterns among tuberculosis patients at a tuberculosis designated hospital in Yunnan: a retrospective analysis of the 2013–2022 period

Dai, J., Li, Q., Chen, J., Zhang, P., Zhao, J., Liu, Y., & Chongsuvivatwong, V. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-12251-0 · Cited by 1

Molecular dynamics insights into allosteric and orthosteric co-targeting of Mycobacterium tuberculosis thymidylate kinase: A structure-based approach for bitopic ligand design

Sivaprakasam, A., Mahendran, R., Vetrivel, U., & Hanna, L. E. (2025) · Results in Engineering · doi:10.1016/j.rineng.2025.108719 · Cited by 1

Pyridine embedded 1,3,4-oxadiazole derivatives: Design, synthesis, molecular docking and antitubercular activity evaluation

Devadiga, D., Ahipa, T. N., Umamaheshwari, S., Bhat, C., Keerthi, S. K., Deepika, D., & Gaonkar, S. L. (2026) · Tuberculosis · doi:10.1016/j.tube.2026.102735 · Cited by 1

Bedaquiline-related QTc Prolongation in Multidrug Resistant Tuberculosis Patients: A Prospective Study

Gupta, A., Pais, C. C., & Babu, S. (2026) · Journal of the Association of Physicians of India · doi:10.59556/japi.74.1361 · Cited by 1

Identification and characterization of inhibitors of the tuberculosis phosphatase PstP

Riedel, C., Rahkola, J., Reichlen, M. J., Ries, H. J., Ericksen, S. S., Voskuil, M., Gitter, A., & Wlodarchak, N. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111316 · Cited by 1

Mycobacterium tuberculosis identification and antibiotic resistance gene profiling using nanopore sequencing: A new approach for tailoring more effective treatments for patients

Li, G., Wu, A., Guo, M., Cram, D., Zheng, Y., Zhu, Z., & Fan, L. (2026) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2026.151725 · Cited by 1

Modulation of NF-κB in tuberculosis - understanding host-pathogen interactions and therapeutic opportunities

Mehraj, S., & Ahmad, Z. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108766 · Cited by 1

The burden of tuberculosis in Latin America: Immunogenetic and socioepidemiological determinants

Silva‐Miranda, M., Lara-Espinosa, J. V., Gordillo-Marroquín, C., Sánchez‐Pérez, H. J., & Hernández‐Pando, R. (2026) · Seminars in Immunology · doi:10.1016/j.smim.2026.102054 · Cited by 1

Extensively Drug Resistant Tuberculosis (XDR-TB) by Phenotypic Drug Susceptibility Using BACTEC Micro MGIT Culture System A Pilot study in Hospital Based Population in Chennai, India

Lakshmipathy, D., Ramasubban, G., Kulandai, L. T., & Rao, M. H. N. (2014) · Cited by 1

Benefits of Therapeutic Drug Monitoring of First Line Antituberculosis Drugs

Pršo, K., Žideková, N., Dohál, M., Porvazník, I., Pršo, M., Kertys, M., & Mokrý, J. (2020) · Acta Medica Martiniana · doi:10.2478/acm-2020-0006 · Cited by 1

PSIKOLOGIS PASIEN MULTI DRUG RESISTAN TUBERKULOSIS SELAMA PENGOBATAN DI PUSKESMAS SENTANI KOTA: STUDI FENOMENOLOGI

Sulistiyani, S., Situmeang, L., & Nur, Q. (2021) · JURNAL KEPERAWATAN TROPIS PAPUA · doi:10.47539/jktp.v4i1.160 · Cited by 1

A Retrospective Study of Synthesis, Structure-Activity Relationship and Antimicrobial Activity of 4-Formyl Pyrazole Containing Isoniazid Moiety: A Review

Chauhan, A., Kumar, A., & Goel, A. (2022) · Asian Journal of Organic & Medicinal Chemistry · doi:10.14233/ajomc.2022.ajomc-p374 · Cited by 1

Multidrug Resistance and Extensively Drug-Resistant Tuberculosis: Diagnosis and Management Protocols

Jasani, V., Abdelaal, A., & Mohamed, M. (2022) · Springer eBooks · doi:10.1007/978-981-16-9495-0_14 · Cited by 1

Social Determinants and Risk Factors Associated with Multi-Drug Resistant Tuberculosis Among Tuberculosis Patients in Tamilnadu – A Case-Control Study

Soundararajan, S. S., Pavithra, G. B., Preeti, P., Nisha, B., Vengadassalapathy, S., Dutta, R., & Parasuraman, G. (2022) · National Journal of Community Medicine · doi:10.55489/njcm.131120222346 · Cited by 1

Management of drug resistant tuberculosis: isoniazid resistant, rifampicin resistant, multi drug resistant, and extensively drug resistant

Bereda, G. (2022) · Journal of Lung Pulmonary & Respiratory Research · doi:10.15406/jlprr.2022.09.00279 · Cited by 1

Research Progress of Cavitary Pulmonary Tuberculosis

岳, 阳. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.133459 · Cited by 1

Call for Integration of Screening of Other Respiratory Diseases of Epidemic Potential in TB Traditional Clinics

Nyirenda, T. E., Moon, S. Y., Jang, S., Choe, J., Yu, S.-H., Chung, D., Kang, R., Mwenye-Phiri, G., Ng’oma, L. M., Mwenyekonde, E., et al. (2023) · Medical Research Archives · doi:10.18103/mra.v11i5.3695 · Cited by 1

PEMBERDAYAAN MASYARAKAT PASIEN TBC DENGAN PENDEKATAN PEMASARAN SOSIAL (IMB)

Adriani, R. B., Lestari, S., Hidayat, N. K., Wahyono, Y., Handayani, S., Sulistyowati, D. A., & Sumardino, S. (2022) · JMM (Jurnal Masyarakat Mandiri) · doi:10.31764/jmm.v6i2.7183 · Cited by 1

Experience of “One Stop TB Diagnostic Solution” Model in Engaging a Private Laboratory for End-to-End Diagnostic Services in the National TB Elimination Program in Hisar, India

Raju, R., Prasad, B. M., Alavadi, U., Saini, S., Sabharwal, M., Duhan, A., Anand, S., Lal, M., Kaur, H., Arora, N., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13172823 · Cited by 1

Eksplorasi Senyawa Penghambat Enzim Salisilat Sintase dari Mycobacterium tuberculosis melalui Studi Penambatan Molekul dan Prediksi Sifat ADME

Arfan, A., Muliadi, R., & Rayani, N. (2023) · Lansau Jurnal Ilmu Kefarmasian · doi:10.33772/lansau.v1i1.9 · Cited by 1

Systematic review of efficacy and safety of shorter regimens for drug-resistant tuberculosis (DR-TB) in children

Jain, L., Malik, M., Kaur, K., Dogra, S., Purohit, A., Sachdeva, M., Chaudhry, M., Pradhan, P., & Mathew, J. L. (2024) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2024.101604 · Cited by 1

Advanced integrative molecular platform for high-throughput screening of drug-resistant tuberculosis

Dakhave, M., Rale, T., Suryawanshi, H. R., Patil, N. S., Suryawanshi, A., Kumar, R. S., Gadekar, S., Bhatnagar, P., Khaire, A., & Wankhede, G. (2024) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2024.116373 · Cited by 1

Faster, higher, stronger: the evolution of clinical perspectives on pan-TB

Fu, L., Deng, G., & Lu, H. (2024) · One Health & Implementation Research · doi:10.20517/ohir.2024.03 · Cited by 1

In Silico Approach: Anti-Tuberculosis Activity of Caespitate in the H37Rv Strain

Moreno-Ceballos, A., Caballero, N. A., Castro, M. E., Perez‐Aguilar, J. M., Маммино, Л., & Meléndez, F. J. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46070387 · Cited by 1

Efektivitas dan keamanan terapi dengan rejimen yang mengandung linezolid dalam pengobatan multidrug-resistant tuberculosis (MDR-TB): Kajian Sistematik

Program Studi Magister Farmasi Fakultas Farmasi Universitas Surabaya, S., Sari, G. A. P. L. P., Herawati, F., & Departemen Farmasi Klinis dan Komunitas, F. F. (2023) · Pharmaceutical Journal of Indonesia · doi:10.21776/ub.pji.2023.008.02.10 · Cited by 1

Therapeutic potential of nano assisted delivery in tuberculosis and its management

Singh, R., Jadhav, K., Jhilta, A., & Verma, R. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13337-4.00019-7 · Cited by 1

Apramycin kills replicating and non-replicating Mycobacterium tuberculosis

Kaur, P., Ramya, V. K., Naveenkumar, C. N., Bharathkumar, K., Singh, M., Hobbie, S. N., Shandil, R. K., & Narayanan, S. (2024) · Frontiers in Tropical Diseases · doi:10.3389/fitd.2024.1413211 · Cited by 1

INTEGRATIVE QSAR ANALYSIS OF OXADIAZOLE DERIVATIVES: RESOLVING MOLECULAR DETERMINANTS FOR ANTI-TUBERCULAR ACTIVITY AND RATIONAL DRUG DESIGN

SUVARNA, N. H., RAJ, V., HAREES, S., Mathew, J. E., Kumar, L., & Verma, R. (2024) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2024v16i5.51468 · Cited by 1

Bioassay-guided isolation and structure elucidation of anti-mycobacterium tuberculosis compounds from Galatella grimmii (Regel & Schmalh.) Sennikov

Shakeri, A., Tajvar, M., Tabrizi, G. T., Soleimanpour, S., Davoodi, J., Asili, J., Amiri, M. S., & Emami, S. A. (2024) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-024-04632-w · Cited by 1

Treatment Strategies for Mycobacterium tuberculosis Infection

Cobongela, S. Z. Z., & Mgwenya, T. N. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1007538 · Cited by 1

Clinical value of serum miRNA-206 in pulmonary tuberculosis

Chu, W., Pan, H., Fei, Z., & Zhang, T. (2024) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2024.12.018 · Cited by 1

Crystal structure of the S -adenosylmethionine-dependent mycolic acid synthase UmaA from Mycobacterium tuberculosis

Teng, S., Wang, J., Sroge, C., Abendroth, J. A., Lorimer, D. D., Horanyi, P. S., Edwards, T. E., Tillery, L. M., Craig, J. K., A, W. C. V. V., et al. (2025) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x25001530 · Cited by 1

Patient advocacy in tuberculosis research and treatment: an interview with Zolelwa Sifumba

Sifumba, Z. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052316 · Cited by 1

The anti-mycobacterial potential of ibuprofen

Shah, P. T., & Xing, L. (2025) · Tuberculosis · doi:10.1016/j.tube.2025.102638 · Cited by 1

Multidrug resistance complexity of Mycobacterium tuberculosis and oxidative stress: the need for innovative drug delivery strategies

Thiagamani, S. M. K., & Vigneswaran, L. V. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24035-5.00011-6 · Cited by 1

Drug Discovery and Computational Strategies in Multi-Drug-Resistant Tuberculosis

Satish, S., Joshi, N., Alavala, R. R., & Khan, A. A. (2025) · Springer eBooks · doi:10.1007/978-981-96-4154-3_26 · Cited by 1

Bioinspired mycobacterial lipid coating of porous particles for enhanced antimicrobial efficacy

Pacheco, J. E. C., Davids, C., Yalovenko, T., Näsström, E., Ahnlund, M., Godaly, G., & Valetti, S. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107225 · Cited by 1

Mapping the immunological research landscape of tuberculosis: A bibliometric review of global trends and clinical themes (2016–2025)

Mathkour, H., & Alamer, E. (2025) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2025.102978 · Cited by 1

Emerging infectious diseases and blood donation

Kjerulff, B. D., & Erikstrup, C. (2018) · ISBT Science Series · doi:10.1111/voxs.12473 · Cited by 1

Case Report: Multidrug-resistant Tuberculosis (MDR TB)

Damayanti, A., & Jannah, A. R. (2018) · Review of Primary Care Practice and Education (Kajian Praktik dan Pendidikan Layanan Primer) · doi:10.22146/rpcpe.41700 · Cited by 1

Efficiency of antimycobacterial chemotherapy in the registered cases of chemoresistance tuberculosis of lungs in Zaporizhzhia region

Raznatovskaya, E. N. (2019) · Likarska sprava · doi:10.31640/jvd.1-2.2019(10 · Cited by 1

A Review of Phenotypic and Genotypic Methods for Detection of Drug Resistance in Mycobacterium tuberculosis

Parsa, S., Soleimanpour, S., Derakhshan, M., Nik, L. B., Mir, R., & Izadi, N. (2020) · Iranian Journal of Medical Microbiology · doi:10.30699/ijmm.14.2.108 · Cited by 1

Model Tatalaksana Komprehensif Tuberculosis Multidrug-Resistant (TB-MDR) Melalui Pendekatan Provider Pelayanan Kesehatan

Irawansa, O. H. Y., Bhaskoro, Y., Maulana, A. R., & Setyawan, F. E. B. (2020) · CoMPHI Journal Community Medicine and Public Health of Indonesia Journal · doi:10.37148/comphijournal.v1i2.15 · Cited by 1

The role of C-Reactive protein as an inflammatory marker to predict prolonged QTc interval in rifampicin-resistant tuberculosis patients: A case-control study

Kusmiati, T., Mertaniasih, N. M., Putranto, J. N. E., Suprapti, B., Soedarsono, S., Luthfah, N., Koesoemoprodjo, W., & Sari, A. P. (2021) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2021.102899 · Cited by 1

Antituberculosis Drug Repurposing: A New Hope for Tackling Multi-Challenging TB in Timely Manner

Majeed, S., Mehraj, S., & Ahmad, Z. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101642 · Cited by 1

Detection of Multi-Drug-Resistance (MDR) Mycobacterium tuberculosis among Suspected Tuberculosis Patients in Bangladesh using Line Probe Assay

Ananna, S. B., Islam, S., Jabeen, I., Ahammad, I., Kamal, S. M. M., Hossain, M. S., Khan, S. M. K., & Hossain, M. (2022) · Bioresearch Communications · doi:10.3329/brc.v8i2.60646 · Cited by 1

The Determinants of Treatment Delay and Quality of Life among the Newly Diagnosed Pulmonary Tuberculosis Patients in Northeastern Thailand: A Cross-Sectional Study

Dadras, O., Thirarattanasunthon, P., Wongrith, P., & Kabmuangpak, S. (2022) · Infectious Disorders - Drug Targets · doi:10.2174/1871526522666220818142651 · Cited by 1

Control of Zoonotic TB: The Need for Multidisciplinary One Health Framework

Asante-Poku, A., Otchere, I. D., Asare, P. P. A., Osei-Wusu, S., Koka, E., & Yeboah‐Manu, D. (2023) · Springer eBooks · doi:10.1007/978-3-031-27164-9_61 · Cited by 1

Design, Synthesis, Molecular Docking, Antitubercular, Antimicrobial and Antioxidant Studies of Some Novel 3-(((1H-Benzo[d]imidazol-2-yl)methyl)thio)-5H-[1,2,4] Triazino[5,6-b]indole Derivatives

Kamera, S., Sharma, V. K., Srivani, M., & Garlapati, A. (2023) · International Journal of Pharmaceutical Sciences and Drug Research · doi:10.25004/ijpsdr.2023.150414 · Cited by 1

Acetyleugenol from Acacia nilotica (L.) exhibits a strong antibacterial activity and its phenyl and indole analogs show a promising anti-TB potentialPreprint

Abdulhamid, A., Adlan, T. A., Ahmed, A. O. A., Koua, F., & Ismail, A. (2020) · Preprints.org · doi:10.20944/preprints202004.0448.v1

Prevalence of Multidrug Resistance TuberculosisPreprint

Bachani, P., Kumar, L., Kumar, N. G., & Shaukat, F. (2020) · Preprints.org · doi:10.20944/preprints202011.0327.v1 · Cited by 1

In Vitro Activity of Tetracycline Analogs against Multidrug-resistant and Extensive drug resistance Clinical Isolates of Mycobacterium tuberculosisPreprint

Ouyang, Q., Lin, D., Deng, G., Wen, Z., Liu, H., Li, H., Cai, Y., & Chen, X. (2019) · doi:10.21203/rs.2.17754/v1 · Cited by 1

Structure based virtual screening, molecular docking and molecular dynamics simulation of drug like small molecules against cell cycle regulator enzyme FtsZ of Mycobacterium tuberculosisPreprint

Mohanty, P. S., Singh, R., Pawar, N., Gogoi, C., Sharma, S. B., Pawar, H. S., & Mohanty, K. K. (2021) · Research Square · doi:10.21203/rs.3.rs-142773/v1 · Cited by 1

Comparative Proteome Analysis Revealed the Differences in Response to both M.tb and Mb Infection of Bovine Alveolar MacrophagesPreprint

Yurong, C., Gao, W., Pu, W., Zhang, G., Xiaoping, W., Lingling, J., Jin, Z., Yujiong, W., & Li, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-843568/v1 · Cited by 1

Tuberculosis Poor Treatment Outcomes and its determinants in Kilifi County, Kenya: A Retrospective Cohort StudyPreprint

Katana, G. G., Ngari, M. M., Maina, T. W., Sanga, D., & Abdullahi, O. A. (2021) · Research Square · doi:10.21203/rs.3.rs-966867/v1 · Cited by 1

Structure-based drug repurposing to inhibit the replication-associated essential protein DnaG of Mycobacterium tuberculosis.Preprint

Ali, W., Jamal, S., Gangwar, R., Ahmed, F., Agarwal, M., Sheikh, J. A., & Grover, S. (2023) · Research Square · doi:10.21203/rs.3.rs-2407410/v1 · Cited by 1

The small mycobacterial ribosomal protein, bS22, modulates aminoglycoside accessibility to its 16S rRNA helix-44 binding sitePreprint

Majumdar, S., Deep, A., Sharma, M. R., Canestrari, J. G., Stone, M., Smith, C., Koripella, R. K., Keshavan, P., Banavali, N. K., Wade, J. T., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.31.535098 · Cited by 2

Epidemiology of first-and second-line anti-tuberculosis drug resistance in new pulmonary tuberculosis cases in Addis Ababa metropolitan area, EthiopiaPreprint

Akalu, G. T., Tessema, B., Sinshaw, W., Amare, M., Diriba, G., Getu, M., Zerihun, B., & Petros, B. (2023) · medRxiv · doi:10.1101/2023.04.20.23288854 · Cited by 1

Combined effect of anti-mycobacterial plant extracts and their inhibitory effect on RNA polymerase and DNA gyrase gene of Mycobacterium tuberculosisPreprint

Tamrakar, V. K., Bhat, J., Parihar, N. S., & Shanmugam, R. (2023) · Research Square · doi:10.21203/rs.3.rs-2909092/v1 · Cited by 1

Antimicrobial Resistance: Challenges in Embedding the Response into the Health System Framework-An Indian PerspectivePreprint

Chandrashekhar, S. R., Prasad, S., Sadanandan, R., & Masthi, N. R. R. (2023) · Preprints.org · doi:10.20944/preprints202308.0521.v1

A 68‐Year‐Old Woman with Recurrent Cystitis

Mutyala, M., Halloush, R. A., & Khasawneh, F. A. (2015) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2015/761829

Innovación y ruptura en la métrica de la poesía en al-Maqāmāt al-Luzūmiyya de al-Saraqusṭī (s. VI/XII)

Ferrando, I. (2016) · Al-Qanṭara · doi:10.3989/alqantara.2016.003

Survival of non-sporulating Bacillus subtilis upon energy limitation

Gray, D. A. (2017)

New Insights in Design and Development of Antitubercular Drugs

Yadav, S., & Narasimhan, B. (2019) · Current Bioactive Compounds · doi:10.2174/1573407215666190409153756

Drug Resistant Tuberculosis: A Major Risk to Global Health Security Treatment

Wani, A. A., & Tanwar, A. (2023) · Haya The Saudi Journal of Life Sciences · doi:10.36348/sjls.2023.v08i07.003

Extensively Drug Resistant-Tuberculosis, XDR-TB

Park, J. S. (2008) · Journal of Korean Medical Association · doi:10.5124/jkma.2008.51.2.168 · Cited by 1

Therapy of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis

Seaworth, B. J., & Griffith, D. E. (2017) · ASM Press eBooks · doi:10.1128/9781555819866.ch9 · Cited by 13

Multidrug resistant to extensively drug resistant tuberculosis: What is next?

Jain, A., & Dixit, P. (2008) · Journal of Biosciences · doi:10.1007/s12038-008-0078-8 · Cited by 113

Management of difficult multidrug‐resistant tuberculosis and extensively drug‐resistant tuberculosis: Update 2012

Chang, K. C., & Yew, W.-W. (2012) · Respirology · doi:10.1111/j.1440-1843.2012.02257.x · Cited by 75